胃癌ERCC1基因甲基化与蛋白表达的关系及其意义

王红兵 陈卫昌

王红兵, 陈卫昌. 胃癌ERCC1基因甲基化与蛋白表达的关系及其意义[J]. 中国肿瘤临床, 2013, 40(23): 1423-1426. doi: 10.3969/j.issn.1000-8179.20131375
引用本文: 王红兵, 陈卫昌. 胃癌ERCC1基因甲基化与蛋白表达的关系及其意义[J]. 中国肿瘤临床, 2013, 40(23): 1423-1426. doi: 10.3969/j.issn.1000-8179.20131375
Hongbing WANG, Weichang CHEN. Methylation of the ERCC1 gene and its protein expression in gastric cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(23): 1423-1426. doi: 10.3969/j.issn.1000-8179.20131375
Citation: Hongbing WANG, Weichang CHEN. Methylation of the ERCC1 gene and its protein expression in gastric cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(23): 1423-1426. doi: 10.3969/j.issn.1000-8179.20131375

胃癌ERCC1基因甲基化与蛋白表达的关系及其意义

doi: 10.3969/j.issn.1000-8179.20131375
详细信息
    通讯作者:

    陈卫昌  wcchen1990@126.com

Methylation of the ERCC1 gene and its protein expression in gastric cancer

More Information
  • 摘要:   目的  检测胃癌组织、相应癌旁组织及正常胃组织中ERCC1蛋白表达情况,探讨ERCC1基因启动子CpG岛甲基化与蛋白表达的关系及其意义。  方法  采用甲基化特异性PCR技术,检测30例胃癌组织、相应癌旁组织、10例正常胃组织中ERCC1基因启动子CpG岛甲基化状态。采用免疫组织化学SP法检测胃癌组织、相应癌旁组织及正常胃组织中ERCC1蛋白的表达情况。  结果  胃癌组织中ERCC1基因启动子CpG岛完全甲基化率为46.7%(14/30),部分甲基化率为30.0%(9/30),总甲基化率为76.7%(23/30),显著高于相应癌旁组织中该基因的甲基化率13.3%(4/30),差异有统计学意义(P < 0.05)。10例正常胃组织中未检测到该基因的甲基化(0/10)。30例胃癌组织中ERCC1蛋白阴性表达率为70.0%(21/30),显著高于相应癌旁组织中蛋白阴性表达率33.3%(10/30),差异有统计学意义。10例正常胃组织中ERCC1蛋白均阳性表达。胃癌组织中发生ERCC1基因启动子CpG岛甲基化其ERCC1蛋白表达率明显低于胃癌组织中未发生ERCC1基因启动子CpG岛甲基化其ERCC1蛋白表达率。  结论  ERCC1基因启动子CpG岛甲基化与其蛋白表达呈负相关,ERCC1基因启动子CpG岛甲基化可能是导致其蛋白表达下调的主要原因之一。

     

  • 表  1  ERCC1基因启动子在不同胃组织中的甲基化率比较

    Table  1.   Comparison between the methylation rates of the ERCC1 promoter among different gastric tissues

    表  2  ERCC1蛋白在不同胃组织中的表达

    Table  2.   Expression of the ERCC1 protein in different gastric tissues

    表  3  胃组织中ERCC1基因启动子CpG岛甲基化及其蛋白表达的关系

    Table  3.   Correlation between ERCC1 promoter methylation and its protein expression

  • [1] Staresincic L, Fagbemi AF, Enzlin JH, et al. Coordination of dual incision and repair synthesis in human nucleotide excision repair[J]. EMBO J, 2009, 28(8): 1111-1120. doi: 10.1038/emboj.2009.49
    [2] Bajpai D, Banerjee A, Pathak S, et al. Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix[J]. Mol Cell Biochem, 2013, 377(1-2): 45-53. doi: 10.1007/s11010-013-1569-y
    [3] Croteau DL, Peng Y, Van Houten B. DNA repair gets physical: mapping an XPA-binding site on ERCC1[J]. DNA Repair (Amst), 2008, 7(5): 819-826. doi: 10.1016/j.dnarep.2008.01.018
    [4] Chen HY, Shao CJ, Chen FR, et al. Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas[J]. Int J Cancer, 2010, 126(8): 1944-1954. doi: 10.1002/ijc.24772
    [5] Gigek CO, Chen ES, Calcagno DQ, et al. Epigenetic mechanisms in gastric cancer[J]. Epigenomics, 2012, 4(3): 279-294. doi: 10.2217/epi.12.22
    [6] Madhusudan S, Smart F, Shrimpton P, et al. Isolation of a small molecule inhibitor of DNA base excision repair[J]. Nucleic Acids Res, 2005, 33(15): 4711-4724. doi: 10.1093/nar/gki781
    [7] Palli D, Polidoro S, D'Errico M, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer[J]. Mutagenesis, 2010, 25(6): 569-575. doi: 10.1093/mutage/geq042
    [8] Deaton AM, Bird A. CpG islands and the regulation of transcription[J]. Genes Dev, 2011, 25(10): 1010-1022. doi: 10.1101/gad.2037511
    [9] Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from[J]? Cancer Sci, 2005, 96(4): 206-211. doi: 10.1111/j.1349-7006.2005.00035.x
    [10] Liu WB, Ao L, Cui ZH, et al. Molecular analysis of DNA repair gene methylation and protein expression during chemical-induced rat lung carcinogenesis[J]. Biochem Biophys Res Commun, 2011, 408(4): 595-601. doi: 10.1016/j.bbrc.2011.04.067
    [11] Lima LM, de Souza LR, da Silva TF, et al. DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors[J]. Histopathology, 2012, 60(3): 489-496. doi: 10.1111/j.1365-2559.2011.04062.x
    [12] Liu ZG, Chen HY, Cheng JJ, et al. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines[J]. Cell Biol Int, 2009, 33(10): 1111-1117. doi: 10.1016/j.cellbi.2009.07.004
    [13] Zhou ZH, Lei YX, Wang CX. Analysis of aberrant methylation in DNA repair genes during malignant transformation of human bronchial epithelial cells induced by cadmium[J]. Toxicol Sci, 2012, 125(2): 412-417. doi: 10.1093/toxsci/kfr320
    [14] Zou XP, Zhang B, Zhang XQ, et al. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions[J]. Hum Pathol, 2009, 40(11): 1534-1542. doi: 10.1016/j.humpath.2009.01.029
    [15] 陈祥锦, 张惠灏, 郑炜, 等. 肝细胞癌p16基因甲基化及其对mRNA表达的影响[J]. 中国癌症杂志, 2005, 15(6): 569-571. doi: 10.3969/j.issn.1007-3639.2005.06.018
  • 加载中
表(3)
计量
  • 文章访问数:  32
  • HTML全文浏览量:  9
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-08-20
  • 修回日期:  2013-11-12

目录

    /

    返回文章
    返回